Canagliflozin reduces atherosclerosis and modulates inflammatory, oxidative pathways in mice

  • Post author:
  • Post category:uncategorized

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at investigating the effect of canagliflozin (Cana) on atherosclerosis and further exploring its potential mechanism. ApoE−/− mice were fed a Western diet (WD) and randomly divided into a WD group and WD+Cana group.